David Menkes
Associate Professor of Psychiatry at the University of Auckland (Waikato Clinical School)
Data updated
Research Footprint
David Menkes appears in 6 tracked papers (2023–2026), most studied alongside LSD, across Microdosing, Anxiety Disorders and Creativity.
Most-cited paper: Acute mood-elevating properties of microdosed LSD in healthy volunteers: a home-administered randomised controlled trial (67 citations).
Frequent co-authors: Suresh Muthukumaraswamy, Robin Murphy and Rebecca Sumner.
Background & Research
David B. Menkes is an academic psychiatrist and associate professor of psychiatry at the University of Auckland’s Waikato Clinical School. His background includes psychology and pharmacology, and his research has focused on psychopharmacology, drug treatments in psychiatry, and the clinical evaluation of low-dose serotonergic agents. He has been a senior author on multiple LSD microdosing studies, including healthy-volunteer, sleep, and major depressive disorder trials.
Key Impact
He is a key clinician-researcher in one of the first modern controlled clinical programs testing LSD microdosing for mood, sleep, and depression outcomes.
Collaboration Network
7 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations David Menkes is associated with.